Site icon OncologyTube

KEYNOTE-426: Pembrolizumab Plus Axitinib VS Sunitinib For Advanced RCC

Elizabeth R. Plimack MD MS @ERPlimackMD Of Fox Chase Cancer Center Discusses KEYNOTE-426: Pembrolizumab Plus Axitinib VS Sunitinib For Advanced RCC.

Exit mobile version